AngioScore develops scoring balloon catheters to treat cardiovascular and peripheral artery diseases.
AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets. Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 9, 2007 | Series E | $30M | 1 | — | — | Detail |
Apr 11, 2006 | Series D | $30M | 1 | — | — | Detail |
Aug 23, 2004 | Series B | $15M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Innomed Ventures | — | Series E |